These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 10705094

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Prognostic relevance of proliferation marker Ki-67 (MIB 1), PCNA and p53 in combined surgically and radiologically treated cancers of the oropharynx and mouth cavity].
    Sittel C, Ruiz S, Kvasnicka HM, Volling P, Jungehülsing M, Eckel HE.
    Laryngorhinootologie; 2000 Feb; 79(2):86-92. PubMed ID: 10738715
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Biological indicators of survival in patients treated by surgery for squamous cell carcinoma of the oral cavity and oropharynx.
    Veneroni S, Silvestrini R, Costa A, Salvatori P, Faranda A, Molinari R.
    Oral Oncol; 1997 Nov; 33(6):408-13. PubMed ID: 9509124
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK, Sessions DG, Lenox J.
    Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
    [Abstract] [Full Text] [Related]

  • 9. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.
    Raybaud H, Fortin A, Bairati I, Morency R, Monteil RA, Têtu B.
    Int J Oral Maxillofac Surg; 2000 Feb; 29(1):36-41. PubMed ID: 10691142
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Significance of p53, PCNA and Ki-67 in the prognosis of squamous cell carcinoma of the oral cavity].
    Sommer T, Olofsson J.
    Laryngorhinootologie; 1997 Mar; 76(3):189-96. PubMed ID: 9213409
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.
    Kato K, Kawashiri S, Yoshizawa K, Kitahara H, Okamune A, Sugiura S, Noguchi N, Yamamoto E.
    J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. p53 and Ki-67 as markers of radioresistance in head and neck carcinoma.
    Couture C, Raybaud-Diogène H, Têtu B, Bairati I, Murry D, Allard J, Fortin A.
    Cancer; 2002 Feb 01; 94(3):713-22. PubMed ID: 11857304
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prognostic significance of apoptosis and associated factors in oral squamous cell carcinoma.
    Stoll C, Baretton G, Ahrens C, Löhrs U.
    Virchows Arch; 2000 Feb 01; 436(2):102-8. PubMed ID: 10755598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.